28 results on '"Tyrosine -- Intellectual property"'
Search Results
2. Patent Issued for Pyrimidines for degrading Bruton's tyrosine kinase (USPTO 12172992)
3. Researchers Submit Patent Application, 'Heteroaryl Heterocyclic Compounds And Uses Thereof', for Approval (USPTO 20240398791)
4. Patent Issued for Substituted pyrazines as inhibitors of BTK, and mutants thereof (USPTO 12086788)
5. Patent Issued for Substituted pyridines, pyridazines, pyrimidines, and 1,2,3-triazines as bruton's tyrosine kinase inhibitors (USPTO 12070457)
6. 'Naphthyridone Compounds For Inhibition Of Raf Kinases And/Or Bcr-Abl Tyrosine Kinases' in Patent Application Approval Process (USPTO 20240287062)
7. Researchers Submit Patent Application, 'Bruton's Tyrosine Kinase (BTK) INHIBITOR AND APPLICATION THEREOF', for Approval (USPTO 20240190864)
8. 'Heteroaryl Heterocyclic Compounds And Uses Thereof' in Patent Application Approval Process (USPTO 20230382916)
9. Patent Issued for 5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases (USPTO 11767321)
10. Patent Application Titled 'Use Of Inhibitors Of Brutons Tyrosine Kinase (Btk)' Published Online (USPTO 20230293532)
11. Patent Application Titled 'Heterocyclic Compounds As Btk Inhibitors' Published Online (USPTO 20230192691)
12. Researchers Submit Patent Application, 'Heteroaryl Heterocyclic Compounds And Uses Thereof', for Approval (USPTO 20230043030)
13. Researchers Submit Patent Application, 'Substituted Aromatic Fused Ring Derivative And Composition Comprising Same, And Use Thereof', for Approval (USPTO 20220380375)
14. 'Pharmaceutical Formulations Of A Bruton'S Tyrosine Kinase Inhibitor' in Patent Application Approval Process (USPTO 20220331252)
15. 'Heteroaryl Heterocyclic Compounds And Uses Thereof' in Patent Application Approval Process (USPTO 20220332719)
16. Patent Issued for ROR1 antibodies (USPTO 11466083)
17. Patent Application Titled 'Btk Inhibitors With Improved Dual Selectivity' Published Online (USPTO 20220298163)
18. Patent Issued for BTK inhibitors with improved dual selectivity (USPTO 11377449)
19. 'Use Of Inhibitors Of Brutons Tyrosine Kinase (Btk)' in Patent Application Approval Process (USPTO 20220175785)
20. Patent Application Titled 'Heteroaryl Heterocyclic Compounds And Uses Thereof' Published Online (USPTO 20220125785)
21. Researchers Submit Patent Application, 'Ocular Implant Containing A Tyrosine Kinase Inhibitor', for Approval (USPTO 20220079876)
22. Patent Application Titled 'Novel Polymorphs Of Acalabrutinib, A Bruton'S Tyrosine Kinase Inhibitor' Published Online (USPTO 20220002302)
23. Patent Issued for Substituted pyrrolo[3,2-d]pyrimidines and pyrazolo[4,3-d]pyrimidines as tyrosine kinase inhibitors (USPTO 11186578)
24. Patent Issued for Succinate forms and compositions of Bruton's tyrosine kinase inhibitors (USPTO 11174243)
25. Patent Issued for Imidazopyrazine Inhibitors Of Bruton'S Tyrosine Kinase (USPTO 10,858,364)
26. Patent Issued for Irreversible Bruton'S Tyrosine Kinase Inhibitor (USPTO 10,669,238)
27. Researchers Submit Patent Application, 'Novel Diamino Pyridine Derivatives', for Approval (USPTO 20200140386)
28. 'Imidazopyridinamine Phenyl Derivative And Use Thereof' in Patent Application Approval Process (USPTO 20190211023)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.